Caris Life Sciences Inc (CAI)

$15.52 -0.13 (-0.83%)
Market Cap 4.35B
Revenue (ttm) 812.03M
Net Income (ttm) -68.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 273.57
Profit Margin -8.39%
Debt to Equity Ratio 0.64
Volume 4,932,100
Avg Vol 3,153,350
Day's Range N/A - N/A
Shares Out 282.68M
Stochastic %K 20%
Beta N/A
Analysts Strong Sell
Price Target $26.92

Company Profile

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions;...

Industry: Biotechnology
Sector: Healthcare
Phone: 866 771 8946
Fax: 866 479 4925
Address:
750 West John Carpenter Freeway, Suite 800, Irving, United States
vu_jade
vu_jade Jul. 23 at 12:50 PM
$CAI growth at a reasonable price .. CAI. Duquesne knows.
0 · Reply
vu_jade
vu_jade Jul. 22 at 5:24 PM
$CAI GAARP
0 · Reply
vu_jade
vu_jade Jul. 21 at 7:43 PM
$CAI all the way up with a red hot poker!
0 · Reply
vu_jade
vu_jade Jul. 21 at 2:39 PM
$CAI full boat!
0 · Reply
PeelonDusk
PeelonDusk Jul. 20 at 8:46 PM
$CAI Is $TEM a threat?
0 · Reply
Amb8675309
Amb8675309 Jul. 20 at 8:05 PM
$CAI adding
0 · Reply
vu_jade
vu_jade Jul. 15 at 7:34 PM
$CAI Keep buying
0 · Reply
vu_jade
vu_jade Jul. 13 at 2:38 PM
$CAI I’ll buy, you fly
0 · Reply
appayip
appayip Jul. 13 at 1:41 PM
$CAI natera is another genetic testing company. its multiples is 12x, while caris is 5x.
1 · Reply
Jtlo
Jtlo Jul. 10 at 7:25 PM
$CAI sell off continues crazy. Does the market not expect a strong earnings report? MC disconnect?
1 · Reply
Latest News on CAI
Caris Life Sciences price target lowered to $30 from $31 at TD Cowen

2026-07-15T12:50:52.000Z - 9 days ago

Caris Life Sciences price target lowered to $30 from $31 at TD Cowen

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

2026-07-14T12:35:10.000Z - 10 days ago

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

Caris Life Sciences price target lowered to $23 from $28 at BofA

2026-07-13T11:15:26.000Z - 11 days ago

Caris Life Sciences price target lowered to $23 from $28 at BofA

Caris Life Sciences price target lowered to $25 from $30 at Evercore ISI

2026-07-06T12:46:21.000Z - 18 days ago

Caris Life Sciences price target lowered to $25 from $30 at Evercore ISI

Caris Life Sciences announces commercial launch of Caris Detect test

2026-07-01T12:35:16.000Z - 23 days ago

Caris Life Sciences announces commercial launch of Caris Detect test

Caris Life Sciences announces dual listing on NYSE Texas

2026-06-16T12:38:34.000Z - 5 weeks ago

Caris Life Sciences announces dual listing on NYSE Texas

Caris Life Sciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 10:40 AM EDT - 6 weeks ago

Caris Life Sciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Caris Life Sciences announces $100M share repurchase program

2026-06-08T12:43:42.000Z - 6 weeks ago

Caris Life Sciences announces $100M share repurchase program

Caris Life Sciences Transcript: AGM 2026

Jun 4, 2026, 11:00 AM EDT - 7 weeks ago

Caris Life Sciences Transcript: AGM 2026

Caris Life Sciences assumed with a Peer Perform at Wolfe Research

2026-06-01T20:57:19.000Z - 7 weeks ago

Caris Life Sciences assumed with a Peer Perform at Wolfe Research

Caris Life Sciences assumed at Peer Perform from Outperform at Wolfe Research

2026-06-01T20:23:59.000Z - 7 weeks ago

Caris Life Sciences assumed at Peer Perform from Outperform at Wolfe Research

Caris Life Sciences Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 1:00 PM EDT - 2 months ago

Caris Life Sciences Transcript: Bank of America Global Healthcare Conference 2026

Caris Life Sciences announces publication of study on measuring TMB using WES

2026-05-11T17:55:47.000Z - 2 months ago

Caris Life Sciences announces publication of study on measuring TMB using WES

Caris Life Sciences submits application to NYSDOH for Caris Assure testing

2026-05-08T23:01:06.000Z - 2 months ago

Caris Life Sciences submits application to NYSDOH for Caris Assure testing

Caris Life Sciences price target lowered to $22 from $28 at Baird

2026-05-08T16:53:15.000Z - 2 months ago

Caris Life Sciences price target lowered to $22 from $28 at Baird

Caris Life Sciences price target lowered to $32 from $38 at BTIG

2026-05-08T13:03:25.000Z - 2 months ago

Caris Life Sciences price target lowered to $32 from $38 at BTIG

Caris Life Sciences price target lowered to $30 from $35 at JPMorgan

2026-05-08T12:26:11.000Z - 2 months ago

Caris Life Sciences price target lowered to $30 from $35 at JPMorgan

Caris Life Sciences price target lowered to $28 from $35 at Citi

2026-05-08T11:34:07.000Z - 2 months ago

Caris Life Sciences price target lowered to $28 from $35 at Citi

Caris Life Sciences reports Q1 EPS 0c, consensus (2c)

2026-05-07T21:18:19.000Z - 2 months ago

Caris Life Sciences reports Q1 EPS 0c, consensus (2c)

Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B

2026-05-07T21:17:18.000Z - 2 months ago

Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B

Caris Life Sciences Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Caris Life Sciences Earnings Call Transcript: Q1 2026

Caris Life Sciences Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Caris Life Sciences Earnings release: Q1 2026

Caris Life Sciences Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Caris Life Sciences Slides: Q1 2026

Caris Life Sciences Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Caris Life Sciences Quarterly report: Q1 2026

Caris Life Sciences’ ChromoSeq receives MolDX approval

2026-05-04T13:08:37.000Z - 2 months ago

Caris Life Sciences’ ChromoSeq receives MolDX approval

Caris Life Sciences Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 3 months ago

Caris Life Sciences Proxy statement: Proxy filing

Caris Life Sciences Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 3 months ago

Caris Life Sciences Proxy statement: Proxy filing

Caris Life Sciences initiated with a Buy at Jefferies

2026-04-12T23:45:06.000Z - 3 months ago

Caris Life Sciences initiated with a Buy at Jefferies

vu_jade
vu_jade Jul. 23 at 12:50 PM
$CAI growth at a reasonable price .. CAI. Duquesne knows.
0 · Reply
vu_jade
vu_jade Jul. 22 at 5:24 PM
$CAI GAARP
0 · Reply
vu_jade
vu_jade Jul. 21 at 7:43 PM
$CAI all the way up with a red hot poker!
0 · Reply
vu_jade
vu_jade Jul. 21 at 2:39 PM
$CAI full boat!
0 · Reply
PeelonDusk
PeelonDusk Jul. 20 at 8:46 PM
$CAI Is $TEM a threat?
0 · Reply
Amb8675309
Amb8675309 Jul. 20 at 8:05 PM
$CAI adding
0 · Reply
vu_jade
vu_jade Jul. 15 at 7:34 PM
$CAI Keep buying
0 · Reply
vu_jade
vu_jade Jul. 13 at 2:38 PM
$CAI I’ll buy, you fly
0 · Reply
appayip
appayip Jul. 13 at 1:41 PM
$CAI natera is another genetic testing company. its multiples is 12x, while caris is 5x.
1 · Reply
Jtlo
Jtlo Jul. 10 at 7:25 PM
$CAI sell off continues crazy. Does the market not expect a strong earnings report? MC disconnect?
1 · Reply
vu_jade
vu_jade Jul. 10 at 1:38 PM
still a great buy $CAI
1 · Reply
Ypestis
Ypestis Jul. 9 at 5:03 PM
$IBRX This sturm und drang allowed me to add 150 more to the Roth. Trading around the core with $CAI.
1 · Reply
Jtlo
Jtlo Jul. 9 at 4:10 PM
$CAI added again
0 · Reply
Jtlo
Jtlo Jul. 8 at 9:34 PM
$CAI earnings should rerate this company 20+
0 · Reply
vu_jade
vu_jade Jul. 8 at 4:41 PM
$CAI buying the dip of the dip
0 · Reply
Jtlo
Jtlo Jul. 8 at 2:06 PM
$CAI in. Will add if it goes lower. Starter.
0 · Reply
WalterWhite13
WalterWhite13 Jul. 7 at 6:35 PM
$CAI this stock should be $150/share
0 · Reply
Nasgarr
Nasgarr Jul. 5 at 10:44 AM
I was thinking of putting about 10% of my allocation (almost only ETFs now) into those 3 stocks, what do you think ? - $CAI (Caris Life Sciences) - $KVYO (Klaviyo) - $WAY (Waystar Holding Corp) Their business is really good I think, aswell as their growth and I think that their share price was wrongly punished since their recent IPOs What do you think please ?
4 · Reply
Ypestis
Ypestis Jul. 4 at 2:27 AM
$CAI Under $20 =
0 · Reply
Ypestis
Ypestis Jul. 3 at 5:22 PM
$CAI This is an easy one to either buy and hold or scalping on the large daily price changes. I think it’s a big winner long term. One more watcher needed for 1000. Very unknown by retail.
2 · Reply
vu_jade
vu_jade Jul. 2 at 4:32 PM
$CAI Great R&R
0 · Reply
vu_jade
vu_jade Jul. 2 at 2:52 PM
$CAI added this pullback
1 · Reply